Pluri Inc. Common Stock (PLUR)
Stock · NASDAQ · Health Care
$0.93as of 10/16/2026
Price chart
Active signals
PLUR Signal Track Record
How signals performed across all stocks →What PLUR's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 28 | +1.4% | 54% | September 8, 2026 |
| Volume Spike | 24 | -10.0% | 33% | October 7, 2026 |
| Bollinger Band Breakout | 19 | -5.2% | 37% | April 17, 2026 |
| 200-Day Moving Average TouchActive now | 17 | -8.1% | 29% | September 22, 2025 |
| Any 20-session window (baseline) | -4.7% | 37% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PLUR
Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and an immunotherapy platform. Its product candidates include PLX-PAD, which is composed…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 92
- Website
- pluri-biotech.com/
Fundamentals
- 1-day range
- $0.85$1.03
- Market cap
- $19.53M
- P/E (trailing)
- —
- P/E (forward)
- -0.54
- EPS (trailing)
- $-2.46
- Dividend yield
- —
- Beta
- 0.72
- Avg. volume
- 26.2K
- Dividend pay date
- July 25, 2019
Pluri Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PLURPluri Inc. Common Stock$0.93▼ 1.06%Market cap $19.53MP/E —$0.9$4.87
- JSPRJasper Therapeutics Inc. Common Stock$0.48▼ 9.77%Market cap $18.10MP/E —$0.3151$2.69
- GRMLGreenland Mines Ltd. Common Stock$6▼ 13.79%Market cap $22.19MP/E —$2.82$27.48
- PASGPassage Bio Inc. Common Stock$3.5▼ 2.78%Market cap $14.11MP/E —$3.29$20
- EVAXEvaxion A/S American Depositary Share$2.83▲ 1.07%Market cap $24.98MP/E —$2.72$12.15
- INTSIntensity Therapeutics Inc. Common stock$3.35▼ 0.89%Market cap $11.49MP/E —$3.1$43.5
- SNTISenti Biosciences Holdings Inc. Common Stock$0.225▼ 14.12%Market cap $11.18MP/E —$0.2399$2.88
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PLUR Pluri Inc. Common Stock | $19.53M | — | $0.93 | ▼ 1.06% | $0.9$4.87 |
| JSPR Jasper Therapeutics Inc. Common Stock | $18.10M | — | $0.48 | ▼ 9.77% | $0.3151$2.69 |
| GRML Greenland Mines Ltd. Common Stock | $22.19M | — | $6 | ▼ 13.79% | $2.82$27.48 |
| PASG Passage Bio Inc. Common Stock | $14.11M | — | $3.5 | ▼ 2.78% | $3.29$20 |
| EVAX Evaxion A/S American Depositary Share | $24.98M | — | $2.83 | ▲ 1.07% | $2.72$12.15 |
| INTS Intensity Therapeutics Inc. Common stock | $11.49M | — | $3.35 | ▼ 0.89% | $3.1$43.5 |
| SNTI Senti Biosciences Holdings Inc. Common Stock | $11.18M | — | $0.225 | ▼ 14.12% | $0.2399$2.88 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- SHORRER DORON · August 20, 2026 · Grant31.6K
- Manieu Alexandre Weinstein · August 20, 2026 · Grant180.0K
- Manieu Alexandre Weinstein · June 30, 2026 · E625.0K
- Manieu Alexandre Weinstein · June 30, 2026 · Grant641
- Manieu Alexandre Weinstein · April 21, 2026 · Grant312.5K @ $2
Institutional Ownership
March 31, 2026
- Total shares held
- 26.9K
- Total value held
- $90.9K
- Institutional holders
- 13
- Unknown19.4K
- Unknown3.1K
- Unknown2.0K
- Unknown1.4K
- Unknown350
- Unknown185
- Unknown125
- Unknown97
- Unknown95
- Unknown93
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Pluri's Subsidiaries Report Major Gains in Cultivated Meat Output
Ever After Foods and Roslin Technologies, part of Pluri, announced significant increases in cultivated meat production. The growth shows the company’s progress in the emerging cultivated meat market. This development could strengthen Pluri’s position as a key player in the sector.
Pluri's Subsidiaries Report Major Gains in Cultivated Meat Output. Ever After Foods and Roslin Technologies, part of Pluri, announced significant increases in cultivated meat production. The growth shows the company’s progress in the emerging cultivated meat market. This development could strengthen Pluri’s position as a key player in the sector.